![](/img/cover-not-exists.png)
The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial
Chris Skedgel, Daniel Rayson, Tallal YounisVolume:
12
Year:
2009
Language:
english
Pages:
8
DOI:
10.1111/j.1524-4733.2009.00511.x
File:
PDF, 191 KB
english, 2009